RecruitingNot Applicable

PDA for Kidneys Study

United States45 participantsStarted 2024-12-19

Plain-language summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Who can participate

Age range1 Minute – 7 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Delivered at \<32 weeks' gestation * ≤72 hours of age * Inpatient at Meriter Hospital, Inc. NICU * At least one parent/guardian is able to provide parental permission in English or Spanish Exclusion Criteria: * Major congenital anomalies of kidney * Attending physician's discretion to not place NIRS sensors due to clinical concerns * In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life * Birth parent aged \<18

What they're measuring

Comparison of patent ductus arteriosus (PDA) echocardiography parameters to kidney hypoxia

Timeframe: Days 1 to 7 of age

Trial details

NCT IDNCT06658496

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01

Contact for this trial

Paige Condit, MD

616-481-9914 pcondit@wisc.edu

View on ClinicalTrials.gov More Patent Ductus Arteriosus trials